Immunological markers of lung disease due to non-tuberculous mycobacteria

Disease Markers

Volumn 29, Issue 2, 2010, Pages 103-109

  Lim, Andrew ^a   Allison, Caris ^a   Tan, Dino Bee Aik ^a   Oliver, Ben ^a   Price, Patricia ^a   Waterer, Grant ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

CXCL10; lung disease; non tuberculous mycobacteria; T cells

Indexed keywords

ANTIBIOTIC AGENT; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCL10; INTERLEUKIN 18; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM; NON TUBERCULOUS MYCOBACTERIA LUNG DISEASE; NONHUMAN; PRIORITY JOURNAL; PROGENY; T LYMPHOCYTE; TREATMENT RESPONSE;

CORYNEBACTERINEAE;

EID: 78649515410     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2010-0732     Document Type: Article

References (23)

1. R. Thomson, D. Looke and A. Konstantinos, Clinical features and five year followup of pulmonary Mycobacterium aviumintracellulare complex (MAC) disease in Queensland, Australia, Respirology 10(Suppl 1) (2005), A80.
2. S.M. Arend, D. van Soolingen and T.H. Ottenhoff, Diagnosis and treatment of lung infection with nontuberculous mycobacteria, Curr Opin Pulm Med 15 (2009), 201-208.
3. Y. Kobashi and T. Matsushima, The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a followup study, Respiration 74 (2007), 394-400.
4. K. Nakanishi, T. Yoshimoto, H. Tsutsui and H. Okamura, Interleukin18 regulates both Th1 and Th2 responses, Annu Rev Immunol 19 (2001), 423-474.
5. M. Torvinen, H. Campwala and I. Kilty, The role of IFNgamma in regulation of IFNgammainducible protein 10 (IP10) expression in lung epithelial cell and peripheral blood mononuclear cell cocultures, Respir Res 8 (2007), 80.
6. Y. Hosokawa, I. Hosokawa, K. Ozaki, H. Nakae and T. Matsuo, Cytokines differentially regulate CXCL10 production by interferongammastimulated or tumor necrosis factoralphastimulated human gingival fibroblasts, J Periodontal Res 44 (2009), 225-231.
7. D.E. Griffith, T. Aksamit, B.A. BrownElliott, A. Catanzaro, C. Daley, F. Gordin, S.M. Holland, R. Horsburgh, G. Huitt, M.F. Iademarco, M. Iseman, K. Olivier, S. Ruoss, C.F. von Reyn, R.J. Wallace, Jr. and K. Winthrop, An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases, Am J Respir Crit Care Med 175 (2007), 367-416.
8. S.Wilton and D. Cousins, Detection and identification ofmultiple mycobacterial pathogens by DNA amplification in a single tube, PCR Methods Appl 1 (1992), 269-273.
9. A. Lim, M.A. French and P. Price, CD4+ and CD8+ T cells expressing FoxP3 in HIVinfected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy, J Acquir Immune Defic Syndr 51 (2009), 248-257.
10. S. Pokkali and S.D. Das, Augmented chemokine levels and chemokine receptor expression on immune cells during pulmonary tuberculosis, Hum Immunol 70 (2009), 110-115.
11. D.G. Russell, Who puts the tubercle in tuberculosis? Nat Rev Microbiol 5 (2007), 39-47.
12. M. Akgun, L. Saglam, H. Kaynar, A.K. Yildirim, A. Mirici, M. Gorguner, M. Meral and K. Ozden, Serum IL18 levels in tuberculosis: comparison with pneumonia, lung cancer and healthy controls, Respirology 10 (2005), 295-299.
13. U. Greinert, M. Schlaak, S. RuschGerdes, H.D. Flad and M. Ernst, Low in vitro production of interferongamma and tumor necrosis factoralpha in HIVseronegative patients with pulmonary disease caused by nontuberculous mycobacteria, J Clin Immunol 20 (2000), 445-452.
14. T.S. Hallstrand, H.D. Ochs, Q. Zhu and W.C. Liles, Inhaled IFNgamma for persistent nontuberculous mycobacterial pulmonary disease due to functional IFNgamma deficiency, Eur Respir J 24 (2004), 367-370.
15. Y.S. Kwon, E.J. Kim, S.H. Lee, G.Y. Suh, M.P. Chung, H. Kim, O.J.Kwon andW.J.Koh, Decreased cytokine production in patients with nontuberculous mycobacterial lung disease, Lung 185 (2007), 337-341. (Pubitemid 350165559)
16. R. Vankayalapati, B. Wizel, B. Samten, D.E. Griffith, H. Shams, M.R. Galland, C.F. Von Reyn,W.M. Girard, R.J.Wallace, Jr. and P.F. Barnes, Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex, J Infect Dis 183 (2001), 478-484.
17. N. Heurlin, S.E. Bergstrom, J. Andersson, M. Christensson and B. Christensson, Lack of Tlymphocytosis and poor interferon gamma production in BAL fluid from HIVnegative immunocompetent patients with pulmonary nontuberculous mycobacteriosis, Scand J Infect Dis 30 (1998), 339-343.
18. M. Ruhwald, M. BjerregaardAndersen, P. Rabna, K. Kofoed, J. EugenOlsen and P. Ravn, CXCL10/IP10 release is induced by incubation of whole blood from tuberculosis patients with ESAT6, CFP10 and TB7.7, Microbes Infect 9 (2007), 806-812.
19. M. Ruhwald, T. Bodmer, C. Maier, M. Jepsen, M.B. Haaland, J. EugenOlsen and P. Ravn, Evaluating the potential of IP10 and MCP2 as biomarkers for the diagnosis of tuberculosis, Eur Respir J 32 (2008), 1607-1615.
20. J. Lighter, M. Rigaud, M. Huie, C.H. Peng and H. Pollack, Chemokine IP10: an adjunct marker for latent tuberculosis infection in children, Int J Tuberc Lung Dis 13 (2009), 731-736.
21. R. Petrucci, N. Abu Amer, R.Q. Gurgel, J.B. Sherchand, L. Doria, C. Lama, P. Ravn, M. Ruhwald, M. Yassin, G. Harper and L.E. Cuevas, Interferon gamma, interferongammainducedprotein 10, and tuberculin responses of children at high risk of tuberculosis infection, Pediatr Infect Dis J 27 (2008), 1073-1077.
22. P. Sansoni, R. Vescovini, F. Fagnoni, C. Biasini, F. Zanni, L. Zanlari, A. Telera, G. Lucchini, G. Passeri, D. Monti, C. Franceschi and M. Passeri, The immune system in extreme longevity, Exp Gerontol 43 (2008), 61-65.
23. P.K. Lam, D.E.Griffith, T.R. Aksamit, S.J. Ruoss, S.M.Garay, C.L. Daley and A. Catanzaro, Factors related to response to intermittent treatment ofMycobacterium avium complex lung disease, Am J Respir Crit Care Med 173 (2006), 1283-1289.